Transition from Basal Bolus to Once-Weekly Subcutaneous Semaglutide and Basal Insulin in Patients with Type 2 Diabetes Mellitus (TRANSITION-T2D)-A Prospective Randomized Controlled Trial

被引：0
|
作者：
Rodriguez, Paloma
Breslaw, Nikki
Bena, James F.
Xiao, Huijun
Jenkins, Kimberly
Isaacs, Diana
Zhou, Keren
Griebeler, Marcio L.
Burguera, Barto
Pantalone, Kevin M.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-74-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
74-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CEA OF ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE VERSUS DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES WITH INADEQUATE GLYCEMIC CONTROL IN CHINA
    Zhen, R.
    Ung, C. O. L.
    Shen, Y.
    Zou, H.
    Xue, Y.
    Wang, Y.
    Hu, H.
    VALUE IN HEALTH, 2022, 25 (07) : S368 - S368
  • [22] Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study
    Bellido, Virginia
    Padin, Cristina Abreu
    Catarig, Andrei-Mircea
    Clark, Alice
    Pittol, Sofia Barreto
    Delgado, Elias
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [23] Efficacy and safety of semaglutide once-weekly vs placebo as add-on to basal insulin alone or in combination with metformin in subjects with type 2 diabetes (SUSTAIN 5)
    Rodbard, H.
    Lingvay, I.
    Reed, J.
    de la Rosa, R.
    Rose, L.
    Sugimoto, D.
    Araki, E.
    Chus, P. -L.
    Wijayasingh, N.
    Norwood, P.
    DIABETOLOGIA, 2016, 59 : S364 - S365
  • [24] Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study
    Mohammedi, Kamel
    Belhatem, Narimene
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Potier, Louis
    DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1855 - 1864
  • [25] Efficacy and safety of semaglutide once-weekly vs placebo as add-on to basal insulin alone or in combination with metformin in subjects with Type 2 diabetes (SUSTAIN 5)
    Rodbard, H.
    Lingvay, I.
    Reed, J.
    de la Rosa, R.
    Rose, L.
    Sugimoto, D.
    Araki, E.
    Chu, P-L
    Wijayasingh, N.
    Norwood, P.
    Subramanian, G.
    DIABETIC MEDICINE, 2017, 34 : 145 - 146
  • [26] Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
    Bergenstal, Richard M.
    Peyrot, Mark
    Dreon, Darlene M.
    Aroda, Vanita R.
    Bailey, Timothy S.
    Brazg, Ronald L.
    Frias, Juan P.
    Johnson, Mary L.
    Klonoff, David C.
    Kruger, Davida F.
    Ramtoola, Shenaz
    Rosenstock, Julio
    Serusclat, Pierre
    Weinstock, Ruth S.
    Naik, Ramachandra G.
    Shearer, David M.
    Zraick, Vivien
    Levy, Brian L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 273 - 285
  • [27] Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
    Xue, Mei
    Shen, Pan
    Tang, Jun
    Deng, Xuan
    Dai, Zhe
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Pamporis, Konstantinos
    Popovic, Djordje S.
    Stachteas, Panagiotis
    Bougioukas, Konstantinos I.
    Fragakis, Nikolaos
    Rizzo, Manfredi
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3648 - 3661
  • [29] BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA
    Bueno, Elvio
    Benitez, Aldo
    Vera Rufinelli, Jazmin
    Figueredo, Rafael
    Alsina, Shirley
    Ojeda, Aldo
    Samudio, Sandra
    Caceres, Mirta
    Arguello, Rocio
    Romero, Fabiola
    Echague, Gloria
    Pasquel, Francisco
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2015, 21 (07) : 807 - 813
  • [30] Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)
    Polonsky, W.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Goldenberg, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S400 - S400
12345